Effect of human plasma on the antimicrobial activity of iclaprim in vitro

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 6, 2007, Pages 1388-1390

  Laue, H ^a   Valensise, T ^a   Seguin, A ^a   Hawser, S ^a   Lociuro, S ^a   Islam, K ^a  

^a Arpida Ltd   (Switzerland)

Author keywords

Antibiotics; MICs; MRSA; Protein binding; Staphylococcus aureus

Indexed keywords

AMINOPYRIDINE DERIVATIVE; FUSIDIC ACID; ICLAPRIM; TEICOPLANIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PLASMA; PROTEIN BINDING; PYRIMIDINES; STAPHYLOCOCCUS AUREUS;

EID: 36448987904     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm392     Document Type: Article

References (10)

1. Hawser S, Lociuro S, Islam K. Dihydrofolate reductase inhibitors as antibacterial agents. Biochem Pharmacol 2006; 71: 941-8.
2. Kompis IM, Islam K, Then RL. DNA and RNA synthesis: Antifolates. Chem Rev 2005; 105: 593-620.
3. Schneider P, Hawser S, Islam K. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. Biborg Med Chem Lett 2003; 13: 4217-21.
4. Morrissey I, Hawser S. Activity of iclaprim against Legionella pneumophila. J Antimicrob Chemother 2007; 60: 905-6.
5. Kohlhoff SA, Roblin PM, Reznik T et al. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. Antimicrob Agents Chemother 2004; 48: 1885-6.
6. Finch FIG, Greenwood D, Norrby SR et al. Antibiotic and Chemotherapy. Anti-infective Agents and Their Use in Therapy. Edinburgh: Churchill Livingstone, 2003.
7. Huebner J, Kropec A, Engels I et al. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid. Chemotherapy 1992; 38: 206-10.
8. Somekh E, Golan T, Tanay A et al. Concentration and bactericidal activity of fusidic acid and cloxacillin in serum and synovial fluid. J Antimicrob Chemother 1999; 43: 593-6.
9. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Seventh Edition: Approved Standard M7-A7 CLSI, Wayne, PA, USA, 2006.
10. Chambers HF, Kennedy S. Effects of dosage, peak and trough concentrations in serum, protein binding and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrob Agents Chemother 1990; 34: 510-4.